We are live on ! Find out more
PASG icon

Passage Bio
PASG

50 hedge funds and large institutions have $33.1M invested in Passage Bio in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more capital invested

Capital invested by funds: $21.3M → $33.1M (+$11.8M)

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

4% more funds holding

Funds holding: 48 → 50 (+2)

0.03% more ownership

Funds ownership: 2.95% → 2.99% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
14
Reduced
10
Closed
7
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$7K

Top Buyers

1
TCM
Tang Capital Management
California
+$1.38M
2
Millennium Management
Millennium Management
New York
+$464K
3
EAM
Erste Asset Management
Austria
+$414K
4
PFCS
Pale Fire Capital SE
Czech Republic
+$333K
5
Renaissance Technologies
Renaissance Technologies
New York
+$158K

Top Sellers

1
BCM
BML Capital Management
Indiana
-$1.35M
2
FLSM
Frazier Life Sciences Management
California
-$1.16M
3
Morgan Stanley
Morgan Stanley
New York
-$103K
4
WMSA
Weiss Multi-Strategy Advisers
New York
-$86.1K
5
Squarepoint
Squarepoint
New York
-$48.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$10.2M – – –
VVM
2
Versant Venture Management
California
$5.01M – – –
EAM
3
Erste Asset Management
Austria
$2.99M +$414K +30,000 +25%
NLVP
4
New Leaf Venture Partners
New York
$2.52M – – –
TCM
5
Tang Capital Management
California
$2.42M +$1.38M +100,000 +500%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.04M +$690 +50 +0%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.24M +$158K +11,448 +23%
BlackRock
8
BlackRock
New York
$1.03M +$7.07K +512 +1%
Millennium Management
9
Millennium Management
New York
$796K +$464K +33,588 +577%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$610K – – –
PFCS
11
Pale Fire Capital SE
Czech Republic
$587K +$333K +24,130 +489%
BCM
12
Bridgeway Capital Management
Texas
$512K – – –
AI
13
Acuitas Investments
Washington
$422K -$290 -21 -0.1%
LCM
14
Lynx1 Capital Management
Puerto Rico
$383K +$130K +9,452 +99%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$336K – – –
Citadel Advisors
16
Citadel Advisors
Florida
$315K +$144K +10,411 +201%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$245K -$86.1K -6,240 -34%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$213K -$20.5K -1,485 -12%
Two Sigma Investments
19
Two Sigma Investments
New York
$203K -$18.7K -1,355 -12%
RC
20
RBF Capital
California
$144K – – –
State Street
21
State Street
Massachusetts
$125K – – –
FT
22
Fiduciary Trust
Massachusetts
$116K – – –
MAM
23
Marquette Asset Management
Minnesota
$86.4K -$386 -28 -0.7%
Northern Trust
24
Northern Trust
Illinois
$77.7K +$16.4K +1,188 +45%
VF
25
Virtu Financial
New York
$68K +$46.7K +3,385 New
1
2 3

PASG Hedge Fund Activity: Q4 2023 in Review

50 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q4 2023, worth a combined $33.1M — up 55% from $21.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PASG positions and 7 closed out — a net gain of 2 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Tang Capital Management, adding an estimated $1.38M. The largest seller was BML Capital Management, exiting entirely with an estimated $1.35M sold.

  • 50 institutional investors held Passage Bio (PASG) as of Q4 2023, up from 48 in Q3 2023.
  • Funds reported $33.1M of Passage Bio stock for Q4 2023, up 55% quarter-over-quarter.
  • 9 funds opened new Passage Bio positions in Q4 2023 and 7 closed out, a net change of +2 holders.
  • The largest Passage Bio buyer in Q4 2023 was Tang Capital Management, an estimated $1.38M added.
  • The largest Passage Bio seller in Q4 2023 was BML Capital Management, an estimated $1.35M sold.

Based on aggregated 13F filings for Q4 2023.